BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 571691)

  • 1. Cyproheptadine in the management of the galactorrhea-amenorrhea syndrome.
    Wortsman J; Soler NG; Hirschowitz J
    Ann Intern Med; 1979 Jun; 90(6):923-5. PubMed ID: 571691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of women with the galactorrhea-amenorrhea syndrome with pyridoxine (vitamin B6).
    McIntosh EN
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1192-5. PubMed ID: 945301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of galactorrhea-amenorrhea syndrome with 2-Br-alpha-ergocryptin (CB 154). Clinical response and pattern of pituitary and steriod hormones before and during therapy.
    Künzig HJ; Geiger W; Schulz KD; Lose KH
    Arch Gynakol; 1975; 218(2):85-94. PubMed ID: 1174026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
    Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical response to CB-154 and the pituitary response to thyrotropin-releasing hormone-gonadotropin-releasing hormone in patients with galactorrhea-amenorrhea.
    March CM; Kletzky OA; Davajan V
    Fertil Steril; 1977 May; 28(5):521-5. PubMed ID: 404198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of brom-ergocryptine in treating amenorrhea/galactorrhea.
    Shapiro AG
    South Med J; 1977 Jun; 70(6):720-1, 725. PubMed ID: 577621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of the amenorrhea-galatorrhea-anovulation syndrome with bromocryptin and the results].
    Markovski N; Ivanov S
    Akush Ginekol (Sofiia); 1980; 19(1):46-52. PubMed ID: 7377513
    [No Abstract]   [Full Text] [Related]  

  • 8. 2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment.
    Barreca P; Giannola C; Palisi F
    Acta Eur Fertil; 1978 Mar; 9(1):21-9. PubMed ID: 567920
    [No Abstract]   [Full Text] [Related]  

  • 9. Ineffectiveness of pyridoxine (B6) to alter secretion of growth hormone and prolactin and absence of therapeutic effects on galactorrhea-amenorrhea syndromes.
    Tolis G; Laliberté R; Guyda H; Naftolin F
    J Clin Endocrinol Metab; 1977 Jun; 44(6):1197-9. PubMed ID: 559690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of prolactin in disturbances of the menstrual cycle].
    Wenner R
    Gynecologie; 1974; 25(2):229-31. PubMed ID: 4448266
    [No Abstract]   [Full Text] [Related]  

  • 11. [2-Br-alpha-ergocryptine in the treatment of amenorrhea-galactorrhea syndromes and in inhibition of puerperal lactation. Effect on secretion of prolactin and pituitary gonadotropin].
    Cagnazzo G; Schonauer S; Lodico G; Lotti G; Delitala G; Masala A
    Minerva Ginecol; 1976 Oct; 28(10):761-70. PubMed ID: 1036769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiserotonin treatment of hyperprolactinemic amenorrhea: long-term follow-up with metergoline, methysergide, and cyproheptadine.
    Crosignani PG; Peracchi M; Lombroso GC; Reschini E; Mattei A; Caccamo A; D'Alberton A
    Am J Obstet Gynecol; 1978 Oct; 132(3):307-12. PubMed ID: 707571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy following thyroid hormone treatment in a patient with amenorrhea-galactorrhea due to primary hypothyroidism.
    Aono T; Shioji T; Onishi T; Kurachi H; Miyai K
    Fertil Steril; 1977 Aug; 28(8):878-80. PubMed ID: 885277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.
    Farrari C; Telloli P; Rampini P; Caldara R
    Gynecol Obstet Invest; 1980; 11(6):317-26. PubMed ID: 6785158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum prolactin level and bromoergocriptine therapy in galactorrhea and oligo- or amenorrhea].
    Baron J; Warenik-Szymankiewicz A; Chwalisz K
    Ginekol Pol; 1981 Jun; 52(6):517-20. PubMed ID: 7197249
    [No Abstract]   [Full Text] [Related]  

  • 17. Bromocryptine therapy in cases of amenorrhea-galactorrhea.
    Mroueh AM; Siler-Khodr TM
    Am J Obstet Gynecol; 1977 Feb; 127(3):291-8. PubMed ID: 576372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bromocriptine treatment of amenorrhea with hyperprolactinemia and galactorrhea].
    Hiroi M; Kawakoshi S; Kaneko N
    Horumon To Rinsho; 1983 Jan; 31(1):95-9. PubMed ID: 6682727
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of response to ergocryptine in the galactorrhea-amenorrhea syndrome.
    Corenblum B; Taylor PJ
    Fertil Steril; 1978 Oct; 30(4):388-92. PubMed ID: 581377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amenorrhea and galactorrhea: results of therapy with 2-Brom-alpha-ergocryptine (CB-154).
    Lloyd SJ; Josimovich JB; Archer DF
    Am J Obstet Gynecol; 1975 May; 122(1):85-9. PubMed ID: 1168997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.